Federal Register Notice: FDA is reopening the comment period until 1/4/16 for the Established Conditions: Reportable Chemistry, Manufacturing, and Controls (CMC) Changes for Approved Drug and Biologic Products; Draft Guidance for Industry, published in the 6/1 Federal Register. To view this notice, click here.
